Explore the latest updates and implications of FDA's evolving SIUU guidance and how these changes impact communication strategies for medical affairs teams
Examine effective channels and platforms for communicating scientific information under the revised FDA guidance, considering digital tools, publications, and stakeholder engagement
Analyze broader trends in healthcare communication and their intersection with FDA SIUU guidance changes.
Address the role of medical affairs in adapting to technological advancements, patient-centric approaches, and regulatory expectations in communication strategies
